Collective Metals Names Devienne Mok CFO-February 2024-www.financetom.com

Collective Metals Names Devienne Mok CFO

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Collective Metals Names Devienne Mok CFO

Nov 15, 2024 2:02 PM

04:40 PM EST, 11/15/2024 (MT Newswires) -- Collective Metals ( CLLMF ) after trade Friday said that it has appointed Devienne Mok as its new chief financial officer, effective immediately.

Mok succeeds Navin Sandhu, who resigned as CFO on Friday, the company added.

She is an experienced accounting and auditing professional with expertise in International Financial Reporting Standards and financial reporting, the company said.

Previous page： Blockchain Company HIVE Digital Plans Texas Relocation & US GAAP Shift - What's On The Cards? Next page： Sector Update: Consumer Stocks Rise Pre-Bell Tuesday

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Blockchain Company HIVE Digital Plans Texas Relocation & US GAAP Shift - What's On The Cards?

Dec 31, 2024

HIVE Digital Technologies Ltd ( HIVE ) shares are trading higher on Tuesday. The company disclosed the strategic relocation of its headquarters from Vancouver, Canada, to San Antonio, Texas. The company has signed a lease agreement for office space. HIVE’s move to San Antonio marks a key growth milestone, aimed at boosting shareholder value, liquidity, and global investor interest. It...

Sector Update: Consumer Stocks Rise Pre-Bell Tuesday

Dec 31, 2024

08:51 AM EST, 12/31/2024 (MT Newswires) -- Consumer stocks were rising in Tuesday's pre-bell hours, with The Consumer Staples Select Sector SPDR Fund ( XLP ) up 0.3% and The Consumer Discretionary Select Sector SPDR Fund ( XLY ) was 0.5% higher. Vera Bradley ( VRA ) shares were up over 2% after the company's largest shareholder, Fund 1 Investments,...

Axsome Therapeutics Mixed Alzheimer's Disease Agitation Data Disappoints but Approvability Seen Likely, Mizuho Says

Dec 31, 2024

08:53 AM EST, 12/31/2024 (MT Newswires) -- Axsome Therapeutics' ( AXSM ) mixed phase 3 outcome for AXS-05 in Alzheimer's disease agitation disappointed, Mizuho said Tuesday, noting that a cleaner 2-for-2 result could have eased approvability doubts and significantly boosted the stock. However, the firm said it remains optimistic about the US Food and Drug Administration's approval, citing the need...

Cocrystal Pharma Extends Phase 2A Influenza Challenge Study; Shares Fall

Dec 31, 2024

08:54 AM EST, 12/31/2024 (MT Newswires) -- Cocrystal Pharma ( COCP ) said Tuesday it plans to extend enrollment in a phase 2a influenza challenge study due to low influenza infection among study participants, making virology results uninterpretable. The study evaluating Cocrystal's investigational inhibitor CC-42344 has shown no serious adverse events so far, the company said. Cocrystal Pharma ( COCP...